Loading...

ATYR ATYR PHARMA INC Earnings Reports 8-K Filing

TYR

TYR

ATYR PHARMA INC

(ATYR)

2025 8-K

Show Summary

Summary

Financial Statements

Financial Statements

Financial Statements

Stock Option Plans

Financial Results

Share Offering Update

Director Appointment

Financial Results

Financial Results

Clinical Trial Enrollment C...

Annual Meeting Approval

Earnings Reports

Earnings Reports

Financial Results Announcement

Investor Conferences

Presentation of Study Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Disinvestment of Assets

Financial Results Announcement

Public Offering

Phase 3 Study Milestone

External Links:

aTyr Pharma Inc. filed an amended 8-K on August 7, 2025, correcting header coding errors in its previous filing regarding its financial results for the quarter ended June 30, 2025. The content of the financial results remains unchanged, and this amendment does not reflect any new financial information.

AI Assistant

ATYR PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.